CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity

Liver diseases are one of the leading causes of mortality in the world, mainly caused by different etiological agents, alcohol consumption, viruses, drug intoxication, and malnutrition. The maturation of gene therapy has heralded new avenues for developing effective interventions for these diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tao, Li, Li, Liu, Yu-chen, Cao, Wei, Chen, Jia-si, Hu, Shuang, Liu, Ying, Li, Liang-yun, Zhou, Hong, Meng, Xiao-ming, Huang, Cheng, Zhang, Lei, Li, Jun, Zhou, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378651/
https://www.ncbi.nlm.nih.gov/pubmed/32760197
http://dx.doi.org/10.7150/ijbs.33481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378651/
https://www.ncbi.nlm.nih.gov/pubmed/32760197
http://dx.doi.org/10.7150/ijbs.33481

Ejemplares similares